Iladatuzumab (Synonyms: MCDS0593A) |
Catalog No.GC26475 |
Iladatuzumab is a humanized IgG1 monoclonal antibody against human CD79B. Iladatuzumab can be used to synthesize ADC active molecule Iladatuzumab vedotin, which has the potential for research on B-cell non Hodgkin lymphoma (B-NHL).
Products are for research use only. Not for human use. We do not sell to patients.
Cas No.: 1906205-76-2
Sample solution is provided at 25 µL, 10mM.
Iladatuzumab (MCDS0593A) is a humanized IgG1 anti-human CD79B monoclonal antibody. Iladatuzumab can be used to synthesize antibody-drug conjugates (ADC) Iladatuzumab vedotin, which has the potential for B-cell non-Hodgkin lymphoma (B-NHL) research[1][2].
References:
[1]. Alex F Herrera, et al. Anti-CD79B Antibody-Drug Conjugate DCDS0780A in Patients with B-Cell Non-Hodgkin Lymphoma: Phase 1 Dose-Escalation Study. Clin Cancer Res. 2022 Apr 1;28(7):1294-1301. [Content Brief]
[2]. Louise Conilh, et al. Payload diversification: a key step in the development of antibody-drug conjugates. J Hematol Oncol. 2023 Jan 17;16(1):3. [Content Brief]
Average Rating: 5
(Based on Reviews and 30 reference(s) in Google Scholar.)GLPBIO products are for RESEARCH USE ONLY. Please make sure your review or question is research based.
Required fields are marked with *